您好,欢迎访问山东省农业科学院文献资源数据库平台

Detection and identification of SARS-CoV-2 and influenza a based on microfluidic technology

文献类型: 外文期刊

作者: Liu, Yujie 1 ; Yu, Guanliu 1 ; Liang, Hongkun 1 ; Sun, Wenbo 2 ; Zhang, Lulu 3 ; Mauk, Michael G. 4 ; Li, Hua 1 ; Chen, Lei 1 ;

作者机构: 1.Shandong Normal Univ, Coll Life Sci, Shandong Prov Key Lab Anim Resistance Biol, Jinan, Shandong, Peoples R China

2.Shandong Acad Agr Sci, Inst Anim Sci & Vet Med, Shandong Key Lab Anim Dis Control & Breeding, Jinan, Shandong, Peoples R China

3.Beijing Univ Chem Technol, Coll Informat Sci & Technol, Beijing, Peoples R China

4.Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA

期刊名称:ANALYTICAL METHODS ( 影响因子:2.7; 五年影响因子:2.7 )

ISSN: 1759-9660

年卷期: 2024 年 16 卷 27 期

页码:

收录情况: SCI

摘要: As of now, the global COVID-19 pandemic caused by SARS-CoV-2, which began in 2019, has been effectively controlled. However, the symptoms of influenza A virus infection were similar to those of SARS-CoV-2 infection, but they required different treatment approaches. To make the detection more accurate and the treatment more targeted. We developed a system that integrates RPA and CRISPR assays, allowing for the rapid, highly specific, and sensitive detection and differentiation of SARS-CoV-2, H1N1, and H3N2. Under isothermal amplification conditions, the RPA-CRISPR Cas12a detection system achieved a detection limit as low as 5 copies per mu L, demonstrating excellent specificity. The measurement time was approximately 30 minutes. The RPA-CRISPR Cas12a detection system combined with the microfluidic chip we designed to simultaneously detect three viruses, providing a potential solution for efficient and reliable diagnosis. We developed a system that integrates RPA-CRISPR Cas12a with microfluidic chip, allowing for the rapid, highly specific, and sensitive detection and differentiation of SARS-CoV-2, H1N1, and H3N2.

  • 相关文献
作者其他论文 更多>>